Bath Savings Trust Co decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,793 shares of the pharmacy operator’s stock after selling 433 shares during the quarter. Bath Savings Trust Co’s holdings in Walgreens Boots Alliance were worth $271,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Prudential PLC purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at $72,774,000. Equity Investment Corp acquired a new position in Walgreens Boots Alliance in the third quarter valued at $42,556,000. State Street Corp grew its position in Walgreens Boots Alliance by 2.5% during the third quarter. State Street Corp now owns 46,444,706 shares of the pharmacy operator’s stock valued at $1,668,294,000 after acquiring an additional 1,115,564 shares during the period. Morgan Stanley increased its stake in Walgreens Boots Alliance by 10.2% during the third quarter. Morgan Stanley now owns 7,460,256 shares of the pharmacy operator’s stock worth $267,973,000 after acquiring an additional 691,989 shares during the last quarter. Finally, ProShare Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 20.0% in the 3rd quarter. ProShare Advisors LLC now owns 3,193,690 shares of the pharmacy operator’s stock worth $114,717,000 after purchasing an additional 531,981 shares during the period. 55.96% of the stock is owned by institutional investors.
In related news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total value of $207,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 16.91% of the stock is owned by insiders.
A number of brokerages have weighed in on WBA. Barclays lifted their price target on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the company an “equal weight” rating in a research report on Friday, January 8th. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Friday, December 18th. ValuEngine raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Tuesday, December 1st. Citigroup cut their price objective on Walgreens Boots Alliance from $43.00 to $40.00 and set a “neutral” rating on the stock in a research report on Friday, October 16th. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $38.00 target price for the company in a research report on Monday. Four investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $44.22.
Shares of WBA stock opened at $48.94 on Thursday. The stock has a market cap of $42.29 billion, a P/E ratio of 97.88, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.32. The stock has a fifty day moving average price of $41.34 and a 200 day moving average price of $39.34. Walgreens Boots Alliance, Inc. has a one year low of $33.36 and a one year high of $54.79.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.03 by $0.19. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion during the quarter, compared to the consensus estimate of $35.01 billion. During the same period in the previous year, the firm posted $1.37 earnings per share. The company’s revenue was up 5.7% on a year-over-year basis. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.84 EPS for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Article: How to Invest in an Index Fund
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.